Form EFFECT ONCOLYTICS BIOTECH INC
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 1, 2026 |
| Accession Number: | 0001104659-26-038081 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONCY secures U.S. patent for pelareorep manufacturing through 2044
- Hanon Systems Supports Youth Education and Talent Development Initiatives Across Global Operations
- Winamp Group Announces the Filing of a U.S. Lawsuit Against NVIDIA and a Major Development in the Belgian Proceedings
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
